-
1
-
-
69949174478
-
Has the era of untreatable infections arrived
-
Livermore DM. Has the era of untreatable infections arrived. J Antimicrob Chemother 2009; 64 Suppl 1: i29-36.
-
(2009)
J Antimicrob Chemother
, vol.64 SUPPL. 1
-
-
Livermore, D.M.1
-
2
-
-
36448983944
-
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
-
Zavascki AP, Goldani LZ, Li J et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007; 60: 1206-15.
-
(2007)
J Antimicrob Chemother
, vol.60
, pp. 1206-1215
-
-
Zavascki, A.P.1
Goldani, L.Z.2
Li, J.3
-
3
-
-
84869451600
-
BSAC standardized disc susceptibility testing method (version 11)
-
Howe RA, Andrews JM. BSAC standardized disc susceptibility testing method (version 11). J Antimicrob Chemother 2012; 67: 2783-4.
-
(2012)
J Antimicrob Chemother
, vol.67
, pp. 2783-2784
-
-
Howe, R.A.1
Andrews, J.M.2
-
4
-
-
84872049998
-
Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22.
-
Clinical and Laboratory Standards Institute. CLSI, Wayne, PA, USA,
-
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22. CLSI, Wayne, PA, USA, 2012.
-
(2012)
-
-
-
5
-
-
84898468240
-
Antimicrobial Susceptibility Testing: Breakpoints 2013
-
EUCAST. (3 May 2013, date last accessed).
-
EUCAST. Antimicrobial Susceptibility Testing: Breakpoints 2013. http:// www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/ Breakpoint_table_v_3.1.pdf (3 May 2013, date last accessed).
-
-
-
-
6
-
-
84898477018
-
Colistin is extensively lost during normal experimental conditions
-
In: Abstracts of the Fifty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, Abstract D-690, American Society for Microbiology, Washington, DC, USA.
-
Karvanen MC, Mohamad A, Lagerback P et al. Colistin is extensively lost during normal experimental conditions. In: Abstracts of the Fifty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2011. Abstract D-690, p. 160. American Society for Microbiology, Washington, DC, USA.
-
(2011)
, pp. 160
-
-
Karvanen, M.C.1
Mohamad, A.2
Lagerback, P.3
-
7
-
-
84869089999
-
Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin
-
Sader HS, Rhomberg PR, Flamm RK et al. Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin. Diagn Microbiol Infect Dis 2012; 74: 412-4.
-
(2012)
Diagn Microbiol Infect Dis
, vol.74
, pp. 412-414
-
-
Sader, H.S.1
Rhomberg, P.R.2
Flamm, R.K.3
-
8
-
-
84878487174
-
Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli
-
Hindler JA, Humphries RM. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol 2013; 51: 1678-84.
-
(2013)
J Clin Microbiol
, vol.51
, pp. 1678-1684
-
-
Hindler, J.A.1
Humphries, R.M.2
-
9
-
-
80051701366
-
Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
-
Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother 2011; 66: 2070-4.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 2070-2074
-
-
Gales, A.C.1
Jones, R.N.2
Sader, H.S.3
|